Literature DB >> 20816094

Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.

Jessica Nouws1, Leo Nijtmans, Sander M Houten, Mariël van den Brand, Martijn Huynen, Hanka Venselaar, Saskia Hoefs, Jolein Gloerich, Jonathan Kronick, Timothy Hutchin, Peter Willems, Richard Rodenburg, Ronald Wanders, Lambert van den Heuvel, Jan Smeitink, Rutger O Vogel.   

Abstract

Acyl-CoA dehydrogenase 9 (ACAD9) is a recently identified member of the acyl-CoA dehydrogenase family. It closely resembles very long-chain acyl-CoA dehydrogenase (VLCAD), involved in mitochondrial beta oxidation of long-chain fatty acids. Contrary to its previously proposed involvement in fatty acid oxidation, we describe a role for ACAD9 in oxidative phosphorylation. ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I. Furthermore, ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation. This strongly contrasts with its evolutionary ancestor VLCAD, which we show is not required for complex I assembly and clearly plays a role in fatty acid oxidation. Our results demonstrate that two closely related metabolic enzymes have diverged at the root of the vertebrate lineage to function in two separate mitochondrial metabolic pathways and have clinical implications for the diagnosis of complex I deficiency. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816094     DOI: 10.1016/j.cmet.2010.08.002

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  71 in total

1.  Early complex I assembly defects result in rapid turnover of the ND1 subunit.

Authors:  Olga Zurita Rendón; Eric A Shoubridge
Journal:  Hum Mol Genet       Date:  2012-05-31       Impact factor: 6.150

2.  A Patient with Complex I Deficiency Caused by a Novel ACAD9 Mutation Not Responding to Riboflavin Treatment.

Authors:  Jessica Nouws; Flemming Wibrand; Mariël van den Brand; Hanka Venselaar; Morten Duno; Allan M Lund; Simon Trautner; Leo Nijtmans; Elsebet Ostergard
Journal:  JIMD Rep       Date:  2013-08-31

3.  Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency.

Authors:  Manuel Schiff; Birgit Haberberger; Chuanwu Xia; Al-Walid Mohsen; Eric S Goetzman; Yudong Wang; Radha Uppala; Yuxun Zhang; Anuradha Karunanidhi; Dolly Prabhu; Hana Alharbi; Edward V Prochownik; Tobias Haack; Johannes Häberle; Arnold Munnich; Agnes Rötig; Robert W Taylor; Robert D Nicholls; Jung-Ja Kim; Holger Prokisch; Jerry Vockley
Journal:  Hum Mol Genet       Date:  2015-02-26       Impact factor: 6.150

4.  Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.

Authors:  Sarah E Calvo; Alison G Compton; Steven G Hershman; Sze Chern Lim; Daniel S Lieber; Elena J Tucker; Adrienne Laskowski; Caterina Garone; Shangtao Liu; David B Jaffe; John Christodoulou; Janice M Fletcher; Damien L Bruno; Jack Goldblatt; Salvatore Dimauro; David R Thorburn; Vamsi K Mootha
Journal:  Sci Transl Med       Date:  2012-01-25       Impact factor: 17.956

Review 5.  Mitochondrial disorders caused by mutations in respiratory chain assembly factors.

Authors:  Francisca Diaz; Heike Kotarsky; Vineta Fellman; Carlos T Moraes
Journal:  Semin Fetal Neonatal Med       Date:  2011-06-15       Impact factor: 3.926

Review 6.  Maintaining ancient organelles: mitochondrial biogenesis and maturation.

Authors:  Rick B Vega; Julie L Horton; Daniel P Kelly
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

7.  Systems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traits.

Authors:  Pénélope A Andreux; Evan G Williams; Hana Koutnikova; Riekelt H Houtkooper; Marie-France Champy; Hugues Henry; Kristina Schoonjans; Robert W Williams; Johan Auwerx
Journal:  Cell       Date:  2012-08-30       Impact factor: 41.582

8.  Lethal Neonatal Progression of Fetal Cardiomegaly Associated to ACAD9 Deficiency.

Authors:  Jennifer Lagoutte-Renosi; Isabelle Ségalas-Milazzo; Marie Crahes; Florian Renosi; Laurence Menu-Bouaouiche; Stéphanie Torre; Caroline Lardennois; Marlène Rio; Stéphane Marret; Carole Brasse-Lagnel; Annie Laquerrière; Soumeya Bekri
Journal:  JIMD Rep       Date:  2015-10-17

9.  Bromodomain Inhibitors Correct Bioenergetic Deficiency Caused by Mitochondrial Disease Complex I Mutations.

Authors:  Joeva J Barrow; Eduardo Balsa; Francisco Verdeguer; Clint D J Tavares; Meghan S Soustek; Louis R Hollingsworth; Mark Jedrychowski; Rutger Vogel; Joao A Paulo; Jan Smeitink; Steve P Gygi; John Doench; David E Root; Pere Puigserver
Journal:  Mol Cell       Date:  2016-09-22       Impact factor: 17.970

Review 10.  Mitochondrial disorders as windows into an ancient organelle.

Authors:  Scott B Vafai; Vamsi K Mootha
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.